Anavex Life Sciences
AVXL
#8659
Rank
C$0.32 B
Marketcap
C$3.49
Share price
-2.75%
Change (1 day)
-80.91%
Change (1 year)

Anavex Life Sciences (AVXL) - Cash on Hand

Cash on Hand as of December 2025 : C$0.18 Billion

According to Anavex Life Sciences 's latest financial reports the company has C$0.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Anavex Life Sciences - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-09-30C$0.14 B-20.13%
2024-09-30C$0.17 B-12.88%
2023-09-30C$0.20 B-0.13%
2022-09-30C$0.20 B6.52%
2021-09-30C$0.19 B395.76%
2020-09-30C$38.91 M32.47%
2019-09-30C$29.37 M-0.22%
2018-09-30C$29.44 M-13.5%
2017-09-30C$34.03 M181.49%
2016-09-30C$12.09 M-40.62%
2015-09-30C$20.36 M150.23%
2014-09-30C$8.13 M2184.33%
2013-09-30C$0.35 M3085.73%
2012-09-30C$0.01 M-91.99%
2011-09-30C$0.13 M-48.83%
2010-09-30C$0.27 M-28.31%
2009-09-30C$0.38 M5531.47%
2008-09-30C$0 M27155.82%
2007-09-30C$0 M-99.82%
2006-09-30C$0.01 M1097.78%
2005-09-30C$0 M-96.77%
2004-09-30C$0.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ligand Pharmaceuticals
LGND
C$1.11 B 500.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$0.47 B 156.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$14.3 M-92.29%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.33 B 80.95%๐Ÿ‡บ๐Ÿ‡ธ USA